title: High dose therapy may have no survival benefit over CHOEP primary chemotherapy for people with aggressive non-Hodgkin's lymphoma.
authors.affiliation: Department of Internal Medicine I, University of Bonn, Germany. glasmacher@uni-bonn.de <glasmacher@uni-bonn.de>
authors.forename: Axel
authors.initials: A
authors.lastname: Glasmacher